Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morton Coleman

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Current Treatment Options in Oncology|July 6, 2004
Epratuzumab in non-Hodgkin's lymphomasRichard R Furman, Morton Coleman, John P Leonard
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|February 24, 2016
Biosimilars: Extrapolating the evidence. A roundtable discussionBradley J Monk, Morton Coleman, Philip Lammers, et al.
Case Reports in Gastroenterology|October 15, 2019
Severe Hepatotoxicity due to Ibrutinib with a Review of Published CasesZaid H Tafesh, Morton Coleman, Clifton Fulmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Phase I to III trials of anti-B cell therapy in non-Hodgkin's lymphomaPeter Martin, Richard R Furman, Morton Coleman, et al.
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
The role of FDG-PET imaging in the management of lymphomaLale Kostakoglu, John P Leonard, Morton Coleman, et al.
Current Oncology Reports|August 11, 2005
New developments in immunotherapy for non-Hodgkin's lymphomaJohn P Leonard, Richard R Furman, Jia Ruan, et al.
Cancer Investigation|November 27, 2002
Thalidomide in multiple myeloma--from the clinic to the laboratoryRebecca Jaslow, Gilla Kaplan, Larry Lyons, et al.
Seminars in Oncology|April 30, 2003
Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasoneMorton Coleman, John Leonard, Larry Lyons, et al.
Dermatology Online Journal|August 27, 2019
Epidermotropic CXCR3 positive marginal zone lymphoma: a distinctive clinical histopathological entity potentially originating in the skin; it does not always indicate splenic marginal zone lymphomaCynthia M Magro, Shabnam Momtahen, Morton Coleman, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2016
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell LymphomaMorton Coleman, Philip E Lammers, Fabio Ciceri, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Current Treatment Options in Oncology|July 6, 2004
Epratuzumab in non-Hodgkin's lymphomasRichard R Furman, Morton Coleman, John P Leonard
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|February 24, 2016
Biosimilars: Extrapolating the evidence. A roundtable discussionBradley J Monk, Morton Coleman, Philip Lammers, et al.
Case Reports in Gastroenterology|October 15, 2019
Severe Hepatotoxicity due to Ibrutinib with a Review of Published CasesZaid H Tafesh, Morton Coleman, Clifton Fulmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Phase I to III trials of anti-B cell therapy in non-Hodgkin's lymphomaPeter Martin, Richard R Furman, Morton Coleman, et al.
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
The role of FDG-PET imaging in the management of lymphomaLale Kostakoglu, John P Leonard, Morton Coleman, et al.
Current Oncology Reports|August 11, 2005
New developments in immunotherapy for non-Hodgkin's lymphomaJohn P Leonard, Richard R Furman, Jia Ruan, et al.
Cancer Investigation|November 27, 2002
Thalidomide in multiple myeloma--from the clinic to the laboratoryRebecca Jaslow, Gilla Kaplan, Larry Lyons, et al.
Seminars in Oncology|April 30, 2003
Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasoneMorton Coleman, John Leonard, Larry Lyons, et al.
Dermatology Online Journal|August 27, 2019
Epidermotropic CXCR3 positive marginal zone lymphoma: a distinctive clinical histopathological entity potentially originating in the skin; it does not always indicate splenic marginal zone lymphomaCynthia M Magro, Shabnam Momtahen, Morton Coleman, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2016
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell LymphomaMorton Coleman, Philip E Lammers, Fabio Ciceri, et al.
Pageof 12